TCON - TRACON ends development of envafolimab exploring strategic options July, 01 2024 10:33 AM TRACON Pharmaceuticals Inc. 2024-07-01 10:33:42 ET More on Tracon TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript Tracon Pharma drops after pivotal data for cancer drug Seeking Alpha’s Quant Rating on Tracon Historical earnings data for Tracon Financial information for Tracon For further details see: TRACON ends development of envafolimab, exploring strategic options